EFFECT OF HORMONE REPLACEMENT THERAPY AND CALCITONIN ON BONE MASS IN POSTMENOPAUSAL WOMEN

被引：15
作者：
MESCHIA, M [1 ]
BRINCAT, M [1 ]
BARBACINI, P [1 ]
MAINI, MC [1 ]
MARRI, R [1 ]
CROSIGNANI, PG [1 ]
机构：
[1] UNIV MALTA,SCH MED,MSIDA,MALTA
来源：
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY | 1992年 / 47卷 / 01期
关键词：
HRT; CALCITONIN; BONE LOSS;
D O I：
10.1016/0028-2243(92)90214-J
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
A total of 104 postmenopausal women were randomly assigned to different therapeutic regimens: (a) calcitonin, (b) estrogen/progestogen (HRT) plus calcitonin, (c) estrogen/progestogen (HRT), (d) and the control group. The bone mass of the lumbar vertebrae of all patients was assessed with a dual beam photon absorptiometer (Norland GD 153). The 73 patients who completed the 1-yr study showed that postmenopausal bone loss could be prevented by either estrogen/progestogen (HRT) or calcitonin. In addition, the combination of hormonel replacement therapy and calcitonin not only prevented postmenopausal bone loss but resulted in a significant 10% gain in bone mass (P < 0.001).
引用
收藏
页码：53 / 57
页数：5
相关论文
共 50 条
  • [41] Effects of Exercise Training on Bone Remodeling, Insulin-Like Growth Factors, and Bone Mineral Density in Postmenopausal Women With and Without Hormone Replacement Therapy
    L.A. Milliken
    S.B. Going
    L.B. Houtkooper
    H.G. Flint-Wagner
    A. Figueroa
    L.L. Metcalfe
    R.M. Blew
    S.C. Sharp
    T.G. Lohman
    Calcified Tissue International, 2003, 72 : 478 - 484
  • [42] Somatic-vegetative Symptoms Evolution in Postmenopausal Women Treated with Phytoestrogens and Hormone Replacement Therapy
    Tit, Delia Mirela
    Pallag, Annamaria
    Iovan, Ciprian
    Furau, Gheorghe
    Furau, Cristian
    Bungau, Simona
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2017, 46 (11) : 1528 - 1534
  • [43] The latest elaboration of the Women's Health Initiative data on hormone replacement therapy and cardiovascular disease in postmenopausal women
    Genazzani, Andrea R.
    Gambacciani, Marco
    Simoncini, Tommaso
    GYNECOLOGICAL ENDOCRINOLOGY, 2007, 23 (04) : 183 - 185
  • [44] Replacement hormone therapy in menauposal women?
    Gompel, A
    REVUE DE MEDECINE INTERNE, 2000, 21 (05): : 405 - 407
  • [45] The effect of tamoxifen and hormone replacement therapy on serum cholesterol, bone mineral density and coagulation factors in healthy postmenopausal women participating in a randomised, controlled tamoxifen prevention study
    Chang, J
    Powles, TJ
    Ashley, SE
    Gregory, RK
    Tidy, VA
    Treleaven, JG
    Singh, R
    ANNALS OF ONCOLOGY, 1996, 7 (07) : 671 - 675
  • [46] Ossein-hydroxyapatite compounds for preventing postmenopausal bone loss -: Coadjuvant use with hormone replacement therapy
    Castelo-Branco, C
    de Osaba, MJM
    Pons, F
    Casals, E
    Sanjuán, A
    Vicente, JJ
    Vanrell, JA
    JOURNAL OF REPRODUCTIVE MEDICINE, 1999, 44 (03) : 241 - 246
  • [47] Effects of hormone replacement therapy on immunological factors in the postmenopausal period
    Abdi, F.
    Mobedi, H.
    Mosaffa, N.
    Dolatian, M.
    Tehrani, F. Ramezani
    CLIMACTERIC, 2016, 19 (03) : 234 - 239
  • [48] Postmenopausal hormone replacement therapy increases plasmatic thromboxane β2
    Oliveira, RLS
    Aldrighi, JM
    Gebara, OE
    Rocha, TRF
    D'Amico, É
    Rosano, GMC
    Ramires, JAF
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2005, 99 (03) : 449 - 454
  • [49] Naloxone decreases insulin secretion in hyperinsulinemic postmenopausal women and may positively affect hormone replacement therapy
    Cucinelli, F
    Soranna, L
    Perri, C
    Romualdi, D
    Barini, A
    Mancuso, S
    Lanzone, A
    FERTILITY AND STERILITY, 2002, 78 (05) : 1017 - 1024
  • [50] Effects of low calcitonin doses on bone remodeling in postmenopausal women with high bone turnover rate
    Campusano, C
    López, JM
    Campino, C
    Cárdenas, I
    Rojas, A
    REVISTA MEDICA DE CHILE, 2000, 128 (04) : 387 - 391
12345